“… 33 , 34 Moreover, synthetic steroids such as dexamethasone, which are widely used drugs to accompany chemotherapy use in CRC patients, may impair glucose metabolism and exacerbate insulin resistance. 35 , 36 Hyperglycaemia is also reported to be associated with platinum-based chemotherapy, 37 , 38 which may not only have a toxic effect on pancreatic β cells, but also inhibit the glycolytic enzymes, contributing to inhibition of insulin. Given the interrelated conditions and bidirectional effects between metabolic disturbance and cancer, more experimental studies are needed to further understand the mechanisms of T2D development in CRC patients.…”